je.st
news
Pfizer, despite dollar and generics fight, still impresses
2015-04-28 20:51:37| Biotech - Topix.net
Cost-cutting and sales of new drugs helped Pfizer overcome a strong dollar and patent expirations to beat Wall Street projections for the first quarter, though it cut its outlook for the year, citing the unfavorable currency exchange rates. The world's second-biggest drugmaker on Tuesday said its 2015 profit forecast includes a negative impact of $3.3 billion from currency exchange, and another $3.5 billion from generic competition.
Tags: still
fight
dollar
pfizer
Category:Biotechnology and Pharmaceuticals